Analytical Data
-
基因名
ER alpha/ESR1
- Application
-
别名
ER-A1; ER; ESR; ESR1; ESRA; NR3A1; NR3-A1; Estrogen Receptor 1; Nuclear Receptor Subfamily 3,Group A,Member 1
-
种属
Human
-
表达系统
E. coli
-
标签
N-His
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
P03372
-
表达区间
Met297~Ser554
-
分子量
33kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
Estrogen receptor alpha (ER alpha), encoded by the ESR1 gene, is a crucial member of the nuclear receptor superfamily and plays a significant role in mediating the effects of estrogens in various physiological processes, including reproductive regulation, breast development, and bone maintenance. Abnormal ESR1 signaling has been implicated in numerous diseases, notably hormone-dependent cancers such as breast cancer. Studying the recombinant form of ER alpha allows researchers to explore its structure, function, and interactions with ligands and other proteins. This understanding is vital for developing targeted therapies that can modulate ER alpha activity. Additionally, the production of recombinant ER alpha facilitates high-throughput screening of potential drug compounds, thus accelerating drug discovery efforts in hormone-related disorders. Advances in protein expression systems have enabled the efficient generation of functional ER alpha, providing valuable insights into its ligand-binding domain, transcriptional activity, and post-translational modifications. As research continues to elucidate the complexities of ER alpha signaling pathways and their implications in health and disease, recombinant ER alpha remains a powerful tool for biotechnological and pharmaceutical advancements.












